Sen. Bernie Sanders and Rep. Elijah Cummings request details after Ariad repeatedly raised the price of its drug. » Read More
There are now more than 11.5 million signed up for Obamacare plans nationwide.
Valeant's interim chairman and CEO say the pharma giant is making changes in "a number of areas" to "correct our missteps."
The controversial former drug exec, facing fraud charges, is also objecting to being a called a "pharma bro."
U.S. tobacco users spend more than $320 billion a year on cigarettes and health care for smoking-related illnesses, according to a study.
Chipotle blew it with consumers and investors in its handling of the E.coli crisis, says media strategist Mark Macias.
The government acted after confirmation the virus hit an Indiana turkey farm, alerting states to the danger and putting workers under surveillance.
Johnson & Johnson said it would cut about 3,000 jobs within its medical devices division, or between 4 percent and 6 percent of the unit's workforce.
UnitedHealth reported a 30 percent rise in quarterly revenue, helped by strength in its Optum pharmacy benefit management business.
The U.K. is enduring Blue Monday, the most depressing day of the year, as the weather worsens and Britons get back into the daily grind.
Over 500 families in the U.K. have prevented organ donations from deceased relatives, refusing thousands of people the chance of a transplant.
About 40 percent of firms that will be required to file new Obamacare tax forms aren't aware of those forms.
A Yale study found that e-cig users who ingested alcohol vapor had worse motor skills despite not feeling drunk.
While President Barack Obama delivered his final State of the Union address on Tuesday, Vice President Joe Biden revealed his cancer "moonshot."
While the biotech sector has been under fire for high drug prices, Biotech CEO says that it brings innovations.
Stretchy and durable smart garments could soon help wearers track their activity and vital signs.
The Facebook founder and CEO dropped himself into the riotous social media debate over childhood vaccines.
Get the best of CNBC in your inbox